Bolt Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 11/14/2025 | 176.06 K | $936.66 K | 0.00% | 9.18% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 137.72 K | $732.68 K | 0.00% | 7.18% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2025 | 94.57 K | $503.13 K | 0.00% | 4.93% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 66.88 K | $355.80 K | -59.92% | 3.49% |
| NAN FUNG GROUP HOLDINGS LTD | 11/13/2025 | 58.35 K | $310.41 K | 0.00% | 3.04% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 48.83 K | $259.78 K | -6.91% | 2.55% |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 11/05/2025 | 35.98 K | $191.40 K | 0.00% | 1.88% |
| VANGUARD GROUP INC | 11/07/2025 | 34.23 K | $182.11 K | -41.47% | 1.79% |
| PFIZER INC | 11/13/2025 | 31.31 K | $166.54 K | 0.00% | 1.63% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 28.63 K | $152.29 K | 56.21% | 1.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 18.53 K | $98.61 K | 0.00% | 0.97% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 16.64 K | $88.54 K | 100.00% | 0.87% |
| SHAY CAPITAL LLC | 11/14/2025 | 15.96 K | $84.90 K | 100.00% | 0.83% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 14.84 K | $78.93 K | 19.76% | 0.77% |
| DRW SECURITIES, LLC | 11/14/2025 | 12.32 K | $65.55 K | 100.00% | 0.64% |
| BLACKROCK, INC. | 11/12/2025 | 9.71 K | $51.66 K | -7.95% | 0.51% |
| MORGAN STANLEY | 11/14/2025 | 3.13 K | $16.64 K | -12.60% | 0.16% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 259 | $1.38 K | -34.43% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 42 | $223 | -2.33% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 31 | $165 | -89.01% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 10 | $53 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 6 | $32 | 100.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 3 | $16 | -98.36% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 10/07/2025 | 2 | $11 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bolt Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Bolt Biotherapeutics, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 176,064
Sofinnova Investments, Inc.: 137,721
Pivotal bioVenture Partners Investment Advisor LLC: 94,573
TANG CAPITAL MANAGEMENT LLC: 66,879
Nan Fung Group Holdings Ltd: 58,347
Samsara BioCapital, LLC: 48,830
41.93% of Bolt Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.69 M shares in the last 24 months. This purchase volume represents approximately $8.99 M in transactions.